or Try an Advanced Search...

    Technical Analysis for ACRV - Acrivon Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 5.86 1.03% 0.06
    ACRV closed up 1.03 percent on Monday, July 1, 2024, on 1.41 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ACRV trend table...
    Date Alert Name Type % Chg
    180 Bearish Setup Bearish Swing Setup 0.00%
    Slingshot Bearish Bearish Swing Setup 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Hammer Candlestick Bullish 1.03%
    Stochastic Buy Signal Bullish 1.03%
    Lizard Bullish Bullish Day Trade Setup 1.03%
    Pocket Pivot Bullish Swing Setup 1.03%
    Older End-of-Day Signals for ACRV ...

       Recent Intraday Alerts

    Alert Time
    Possible Pocket Pivot about 5 hours ago
    3x Volume Pace about 10 hours ago
    2x Volume Pace about 10 hours ago
    1.5x Volume Pace about 10 hours ago
    Up 5% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ACRV Chart by TradingView
    Basic chart:

    Profile

    Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops precision oncology medicines. The company's lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1/2 for use in the treatment of platinum-resistant ovarian cancer; endometrial and bladder cancer; and SCCs, including SCCHN, cervical, and anal cancer. It is also developing two preclinical drug programs used to predict tumor sensitivity based on custom OncoSignature tests. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Oncology Tumor Ovarian Cancer Bladder Cancer Gynaecological Cancer Anal Cancer

    Is ACRV a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 21 Is Acrivon Therapeutics, Inc. (ACRV) Stock Outpacing Its Medical Peers This Year?
    Jun 13 Acrivon Therapeutics: Can You Win In Clinical Trials With Selection Bias?
    Jun 5 Is Acrivon Therapeutics, Inc. (ACRV) Outperforming Other Medical Stocks This Year?
    May 29 Acrivon Therapeutics to Present at the Jefferies Global Healthcare Conference
    May 28 Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock
    May 24 5 Small Drug Stocks to Buy From a Recovering Industry
    May 20 Has Acrivon Therapeutics, Inc. (ACRV) Outpaced Other Medical Stocks This Year?
    May 14 Acrivon Therapeutics GAAP EPS of -$0.73 beats by $0.11
    May 14 Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
    May 10 Is a Surprise Coming for Acrivon Therapeutics (ACRV) This Earnings Season?
    See more ACRV news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.5
    52 Week Low 3.19
    Average Volume 166,561
    200-Day Moving Average 6.23
    50-Day Moving Average 7.89
    20-Day Moving Average 6.83
    10-Day Moving Average 6.22
    Average True Range 0.46
    RSI (14) 30.56
    ADX 20.34
    +DI 17.42
    -DI 27.86
    Chandelier Exit (Long, 3 ATRs) 6.76
    Chandelier Exit (Short, 3 ATRs) 6.89
    Upper Bollinger Bands 8.20
    Lower Bollinger Band 5.46
    Percent B (%b) 0.15
    BandWidth 40.12
    MACD Line -0.57
    MACD Signal Line -0.48
    MACD Histogram -0.0968
    Fundamentals Value
    Market Cap 130.06 Million
    Num Shares 22.2 Million
    EPS -2.26
    Price-to-Earnings (P/E) Ratio -2.59
    Price-to-Sales 0.00
    Price-to-Book 0.57
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.40
    Resistance 3 (R3) 6.44 6.29 6.31
    Resistance 2 (R2) 6.29 6.15 6.27 6.28
    Resistance 1 (R1) 6.08 6.07 6.18 6.04 6.25
    Pivot Point 5.93 5.93 5.98 5.91 5.93
    Support 1 (S1) 5.72 5.79 5.82 5.68 5.47
    Support 2 (S2) 5.57 5.71 5.55 5.44
    Support 3 (S3) 5.36 5.57 5.41
    Support 4 (S4) 5.32